GenMark Diagnostics Announces Pricing of Its Initial Public Offering
GenMark Diagnostics announced that its initial public offering of 4,600,000 shares of its common stock has been priced at $6.00 per share. T
Read MoreMonth: June 2010
Proteoderm Announces New Formula for Personalized Skin Product
Proteoderm Inc announced that it has successfully developed a new formulation of Proteoderm. The new formulation will be only available at licensed health professionals’ offices.
Read MoreHitachi Software and OriGene Technologies Announce Collaboration
Hitachi Software and OriGene Technologies announced a co-marketing agreement to jointly promote OriGene’s multiplex assays built on Luminex xMAP/Bio-Plex technology and Hitachi Software’s MasterPlex software suite for analysis and reporting of multiplex assay data.
Read More
Chemistry Controls: Boring, Necessary, Valuable
Chemistry controls are a laboratory must, and innovation is subtle but constant.
Read MoreTcLand Expression Gets $552,000 for Rheumatoid Arthritis Diagnostic Program
TcLand Expression SA announced that the company and its collaborative partners have been awarded 450,000 in research funding by the French National Research Agency (ANR) for a companion diagnostic program in rheumatoid arthritis.
Read More